http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-199902570-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a6bc006fc29a568f3aceb821dd2135e |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate | 2000-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dc6d4f16cb167f31dd1aaca0ab4fa9c |
| publicationDate | 2002-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TR-199902570-A2 |
| titleOfInvention | Antipsoriatic forte cream |
| abstract | 0.50% Anthraline, 0.20% Salicylic acid, 0.15% Methylparaben, 0.15% Propylparaben, 2.08% PEG-7 Glyceryl cocoate, 2.08% Stearyl alcohol, 3.00% Propylene glycol, 3.00% Glycerine, 4.16% Isopropyl myristate, 8.29% Liquid vaseline,% 10.39 Glyceryl stearate, Steareth-25, Ceteth-20 and Stearyl alcohol, 66.00% Antipsoriatic cream with distilled water. It is a drug used in the topical treatment of chronic psoriasis. It is a specific drug of psoriasis on the skin and hair area. Each item constituting the composition of the product has been carefully selected and presented to the use of the consumer, whose usage rates have been determined to provide optimum effect as a result of long studies. |
| priorityDate | 2000-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.